biotech / news / / The Manila Times
Sonogenetics is a new modality using ultrasound to precisely control specific cells ‘tagged’ with special proteins.
SonoNeu has emerged from stealth to commercialize sonogenetics as a drug-free therapeutic platform.
KEY POINTS
- The ARPA-H awarded up to $41.3 million for a six-year, multi-institution sonogenetics research collaboration.
- Sonogenetics enables precise, noninvasive control of specific cells using ultrasound-responsive proteins.
- The project aims to develop wearable ultrasound devices paired with engineered proteins for targeted therapy.
- Sonogenetics could provide non-invasive brain-computer interfaces and deep brain stimulation without implants.
COMPANIES
Summarized by Newsio from The Manila Times. How we summarize →